10-Q · May 15, 2026
Shuttle Pharmaceuticals Holdings, Inc. continues to face operational challenges with a reported net loss of $2.15 million for Q1 2026, which marks a 29% improvement from the previous year. The company has completed an…
Earnings analysis · 10-Q
Filed September 24, 2026 · Our reading of the company's report
The latest report
The filing does not provide current-period income statement, balance-sheet, or cash-flow figures, so no quarter-over-quarter or year-over-year operating trend can be established. The principal developments are the…
The filing does not provide current-period income statement, balance-sheet, or cash-flow figures, so no quarter-over-quarter or year-over-year operating trend can be established. The principal developments are the acquisition and planned expansion of United Dogecoin, including 500 rigs purchased, an additional 2,500 contemplated, and a targeted 43,200 GH/s hash rate. Sentiment is bearish because controls remain ineffective as of June 30, 2026, mining operations have not started, key power and colocation agreements are not finalized, and the company faces a claim for approximately $250,000 plus 2.99% of United Dogecoin.
Management has initiated remediation measures for the control deficiencies, including engaging a third-party consulting firm for SEC reporting and technical accounting matters. The remediation discussion applies to the period ended June 30, 2026.
United Dogecoin purchased 500 Dogecoin mining rigs and expects to purchase an additional 2,500 rigs when funds permit, indicating a defined initial equipment expansion plan.
United Dogecoin is targeting approximately 1.5% of global Dogecoin mining capacity and anticipates a 43,200 GH/s hash rate, providing stated scale objectives for the planned business.
Management concluded that disclosure controls and procedures were ineffective as of June 30, 2026 and identified material weaknesses involving accounting close processes, IT general controls, entity-level communication, and technical accounting expertise.
United Dogecoin has not yet initiated cryptocurrency mining operations and has not entered colocation or finalized power supply agreements. These gaps could delay or prevent the anticipated 43,200 GH/s hash rate and related revenue generation.
A former consultant seeks approximately $250,000 and 2.99% of United Dogecoin's common stock, or equivalent convertible preferred stock. The litigation is in its early stages and the company cannot express an opinion on the outcome.
United Dogecoin has only purchased 500 mining rigs and expects to buy another 2,500 when funds permit, creating substantial capital, equipment-availability, and execution risk before reaching its planned scale.
The company expects to rely on third-party colocation providers and mining pool operators, while power is expected to be sourced through ERCOT. The filing identifies risks from outages, cybersecurity incidents, volatile electricity pricing, and service-provider failures.
United Dogecoin's planned business is concentrated in Dogecoin and targets approximately 1.5% of global Dogecoin mining capacity. The filing warns that volatility, regulatory changes, unlimited supply, and competition could materially reduce asset values and mining profitability.
The filing provides no quantitative revenue or EPS guidance. United Dogecoin discusses anticipated operations, including a 43,200 GH/s hash rate and a goal of approximately 1.5% of global Dogecoin mining capacity, but provides no financial outlook.
Shuttle Pharmaceuticals Holdings, Inc. continues to face operational challenges with a reported net loss of $2.15 million for Q1 2026, which marks a 29% improvement from the previous year. The company has completed an…
This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.